This contract expires in 84 days (Sep 30, 2026).
CAREDX LAB SOLUTIONS INC - 26-000014 CAREDX LAB SOLUTIONS INC. ALLO SEQ TX17 NEXT GENERATION SEQUENCING (NGS) REAGENT KITS
Key Details
Description
26-000014 CAREDX LAB SOLUTIONS INC. ALLO SEQ TX17 NEXT GENERATION SEQUENCING (NGS) REAGENT KITS
Context & Analysis
On Jan 16, 2026, Department of Health and Human Services obligated $292,972.8 to CAREDX LAB SOLUTIONS INC for 26-000014 caredx lab solutions inc. allo seq tx17 next generation sequencing (ngs) reagent kits. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in WEST CHESTER, PA. The contract is scheduled through Sep 30, 2026 — approximately 3 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.